Developer docs
API playgroundTry for free, no card

Search company profiles

Specipig

Full company profile

uuid002ckzr

Namestring
Specipig
Legal namestring
Specipig
Websiteurl
specipig.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Specipig is a preclinical Contract Research Organization (CRO) headquartered in El Prat de Llobregat (Barcelona), Spain, with operations dating back to 2012-2013. The company specializes in porcine (pig) models for biomedical research and operates a vertically integrated model that combines proprietary miniature pig breeding (the Specipig brand) with full-service preclinical CRO capabilities marketed under the Versa Biomedical brand, formally launched in April 2025. Versa Biomedical delivers GLP-certified in vivo preclinical studies for medical device, pharmaceutical, biotechnology, and academic sponsors, covering drug development (pharmacokinetics, toxicokinetics, toxicity, pharmacodynamics, efficacy, safety), medical device biocompatibility testing, and bespoke disease models across ophthalmology, radiology, cardiology, neurology, endoscopy, urology, and dental/maxillofacial disciplines.

The underlying technology stack is operational rather than digital: an in-house miniature pig breeding program, three fully equipped research sites plus an analytical laboratory totaling 2,400 square metres (expanded 2022), a neonatal intensive care unit (opened 2022), and a network of specialist surgeon collaborators. Regulatory scaffolding includes GLP certification equivalent to FDA 21 CFR Part 58, ISO 13485, and ISO 9001, positioning the firm for regulated medical device and pharmaceutical submissions.

The business model is project-based B2B professional services revenue: each contract is individually scoped, quotation-based (pricing not publicly disclosed), with study initiation timelines of 1 to 3 months. GTM is enterprise field sales, supported by a dedicated Head of Commercial and BD (Assela Bosch), direct sales outreach at conferences such as BIO International Convention 2025, and a content/news presence on its website. The firm has completed over 200 customized projects for sponsors across 14 countries over 12 years of operation. Primary customer segments are medical device companies, pharmaceutical companies, and biotechnology companies; research institutes form a secondary segment. Ownership is private and founder/management-controlled, with no disclosed venture capital or institutional backing.

Short descriptiontext

Specipig is a Barcelona-based preclinical CRO specializing in porcine models, combining proprietary miniature pig breeding with GLP, ISO 13485, and ISO 9001-certified preclinical research services for pharmaceutical, biotechnology, and medical device sponsors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBarcelona, Spain
HQ citystring
Barcelona
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
preclinical CRO services, porcine model research, contract research organization, biomedical animal models, medical device preclinical testing
Industry4 codes
PRIMARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)
SECONDARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYAFAEAEAL
High-Health/Biosecure Hog Production (SPF/Pedigree Nucleus)
SECONDARYAFAEAEAH
Feeder Pig Production & Sales
NAICS code3 codes
  • Animal Production and Aquaculture112
  • Support Activities for Animal Production11521
  • Hog and Pig Farming112210
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Preclinical Contract Research Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Preclinical Contract Research Services
TypeProfessional Services
Description

The company provides preclinical CRO services including in vivo studies, preclinical trials for medical devices, and drug development services for pharmaceutical companies. Revenue is generated through project-based contracts that can range from 1 to 3 months to initiate.

versabiomedical.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Specipig is a preclinical Contract Research Organization specialized in porcine (pig) models that delivers contract research services to pharmaceutical, biotechnology, and medical device companies. The company combines its own miniature pig breeding program with full-service CRO capabilities (under the Versa Biomedical brand), designing flexible, ad hoc in vivo studies including preclinical trials, pharmacokinetics, toxicokinetics, efficacy and safety studies, and biocompatibility/device testing under GLP, ISO 13485, and ISO 9001 certifications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Over 200 customized projects completed in 14 countries over 12 years
Product overview1 text field

Specipig operates as a two-part organization: Specipig breeds and markets miniature pigs for biomedical research, while Versa Biomedical provides full-service preclinical CRO capabilities. Together, they offer an integrated preclinical research solution combining proprietary animal models with comprehensive contract research services, enabling pharmaceutical companies to conduct drug development studies and medical device companies to perform device testing and biocompatibility studies.

Product and service2 records
1Versa Biomedical Preclinical CRO Services
CategoryPreclinical Contract Research Services
Description

Full-service preclinical contract research for pharmaceutical, biotechnology, and medical device companies, including in vivo studies, GLP-compliant preclinical trials, pharmacokinetics, toxicokinetics, efficacy and safety studies, device testing, and regulatory submission support. Delivered onsite at the company's GLP-certified facilities in Barcelona.

2Specipig Miniature Pigs for Preclinical Research
CategoryPreclinical Animal Models
Description

Proprietary miniature pigs bred and supplied by Specipig for use in preclinical biomedical, pharmaceutical, and medical device research programs. Provided as an integrated animal model supply alongside CRO services.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

UPyTher selected Versa Biomedical for development of their custom drug delivery solution for treatment of peritoneal diseases including metastasized colorectal and ovarian cancer.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Collaborative research partnership where CMN research group researchers developed and established a novel reproducible and minimally invasive ischemic stroke model in swine, leveraging Versa Biomedical's facilities and expertise.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Zircon selected Versa Biomedical for preclinical development of Y-TZP Zirconia implant solution, conducting studies for dental implant applications.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global preclinical CRO with extensive in vivo and safety assessment services. Specipig and WuXi compete for outsourced preclinical study contracts from international pharma/biotech sponsors, though WuXi operates at much greater scale.

TypeBroad incumbent
Description

Global preclinical CRO with broad species coverage including swine models for safety assessment and biomedical research. Comparable as a direct competitor in the preclinical CRO category but at vastly larger scale with rodents, NHPs and additional services beyond Specipig's pig-model niche.

TypeBroad incumbent
Description

Large CRO offering preclinical services including large-animal and medical device programs. A relevant buyer consideration for any sponsor choosing between full-service incumbents and a specialized mini-pig CRO like Specipig.

TypeBroad incumbent
Description

Preclinical CRO and research models provider offering surgical and toxicology services, including large-animal capabilities. Competitor for preclinical study outsourcing work across pharma and medical device sponsors.

TypeEmerging player
Description

Provider of research models including minipigs (Göttingen and Sinclair lines) and contract research services. Comparable as a combined model supplier + services organization targeting the same preclinical sponsor base.

TypeDirect peer
Description

Preclinical CRO specializing in minipig and other large-animal models for safety, pharmacology and medical device studies. Closest niche competitor given overlapping minipig expertise and sponsor profile (pharma + medtech).

TypeEmerging player
Description

Preclinical CRO with oncology and translational research expertise, including large-animal and surgical model capability. Comparable preclinical services target customer and CRO sale motion (pharma/biotech sponsorship).

TypeBroad incumbent
Description

Preclinical CRO with NHP and large-animal experience supporting safety assessment and regulatory toxicology for pharma and device sponsors. Comparable CRO sale motion and regulatory-grade deliverables to Versa Biomedical's offering.

TypeDirect peer
Description

Leading commercial breeder and supplier of Göttingen minipigs for biomedical research worldwide. Directly comparable to Specipig's animal-model supply side and overlap with the CRO buyer base for porcine preclinical studies.

TypeBroad incumbent
Description

Drug discovery and preclinical CRO with growing in vivo capabilities. Indirect competitor for outsourced preclinical work and a potential partner or acquirer of niche preclinical capabilities like Specipig's.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses6 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Specipig

Preclinical Contract Research Servicesspecipig.com

Specipig is a Barcelona-based preclinical CRO specializing in porcine models, combining proprietary miniature pig breeding with GLP, ISO 13485, and ISO 9001-certified preclinical research services for pharmaceutical, biotechnology, and medical device sponsors.

What Specipig does

Specipig is a preclinical Contract Research Organization (CRO) headquartered in El Prat de Llobregat (Barcelona), Spain, with operations dating back to 2012-2013. The company specializes in porcine (pig) models for biomedical research and operates a vertically integrated model that combines proprietary miniature pig breeding (the Specipig brand) with full-service preclinical CRO capabilities marketed under the Versa Biomedical brand, formally launched in April 2025. Versa Biomedical delivers GLP-certified in vivo preclinical studies for medical device, pharmaceutical, biotechnology, and academic sponsors, covering drug development (pharmacokinetics, toxicokinetics, toxicity, pharmacodynamics, efficacy, safety), medical device biocompatibility testing, and bespoke disease models across ophthalmology, radiology, cardiology, neurology, endoscopy, urology, and dental/maxillofacial disciplines.

The underlying technology stack is operational rather than digital: an in-house miniature pig breeding program, three fully equipped research sites plus an analytical laboratory totaling 2,400 square metres (expanded 2022), a neonatal intensive care unit (opened 2022), and a network of specialist surgeon collaborators. Regulatory scaffolding includes GLP certification equivalent to FDA 21 CFR Part 58, ISO 13485, and ISO 9001, positioning the firm for regulated medical device and pharmaceutical submissions.

The business model is project-based B2B professional services revenue: each contract is individually scoped, quotation-based (pricing not publicly disclosed), with study initiation timelines of 1 to 3 months. GTM is enterprise field sales, supported by a dedicated Head of Commercial and BD (Assela Bosch), direct sales outreach at conferences such as BIO International Convention 2025, and a content/news presence on its website. The firm has completed over 200 customized projects for sponsors across 14 countries over 12 years of operation. Primary customer segments are medical device companies, pharmaceutical companies, and biotechnology companies; research institutes form a secondary segment. Ownership is private and founder/management-controlled, with no disclosed venture capital or institutional backing.

Specipig firmographics

Firmographics
Name
Specipig
Legal name
Specipig
Website
https://specipig.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
1–10 employees
Short description
Specipig is a Barcelona-based preclinical CRO specializing in porcine models, combining proprietary miniature pig breeding with GLP, ISO 13485, and ISO 9001-certified preclinical research services for pharmaceutical, biotechnology, and medical device sponsors.
Ownership category
akta.pro rank

Specipig industry classification

Industry
Product category
Preclinical Contract Research Services
NAICS
Animal Production and Aquaculture (112), Support Activities for Animal Production (11521), Hog and Pig Farming (112210)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)
SECONDARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYAFAEAEAL
High-Health/Biosecure Hog Production (SPF/Pedigree Nucleus)
SECONDARYAFAEAEAH
Feeder Pig Production & Sales

Keywords

  • Preclinical CRO services
  • Porcine model research
  • Contract research organization
  • Biomedical animal models
  • Medical device preclinical testing

Where Specipig is headquartered

Location

Headquarters

HQ city
Barcelona
HQ country
Spain
HQ region
Europe

Offices1 record

Markets served

Specipig business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales, Technology or R&D

Revenue model

  1. Preclinical Contract Research Services: The company provides preclinical CRO services including in vivo studies, preclinical trials for medical devices, and drug development services for pharmaceutical companies. Revenue is generated through project-based contracts that can range from 1 to 3 months to initiate.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Specipig product offering

Product offering

Core offering

Specipig is a preclinical Contract Research Organization specialized in porcine (pig) models that delivers contract research services to pharmaceutical, biotechnology, and medical device companies. The company combines its own miniature pig breeding program with full-service CRO capabilities (under the Versa Biomedical brand), designing flexible, ad hoc in vivo studies including preclinical trials, pharmacokinetics, toxicokinetics, efficacy and safety studies, and biocompatibility/device testing under GLP, ISO 13485, and ISO 9001 certifications.

Product overview

Specipig operates as a two-part organization: Specipig breeds and markets miniature pigs for biomedical research, while Versa Biomedical provides full-service preclinical CRO capabilities. Together, they offer an integrated preclinical research solution combining proprietary animal models with comprehensive contract research services, enabling pharmaceutical companies to conduct drug development studies and medical device companies to perform device testing and biocompatibility studies.

Differentiator

Problem solved

Functional benefit

Products and services

  • Versa Biomedical Preclinical CRO Services Full-service preclinical contract research for pharmaceutical, biotechnology, and medical device companies, including in vivo studies, GLP-compliant preclinical trials, pharmacokinetics, toxicokinetics, efficacy and safety studies, device testing, and regulatory submission support. Delivered onsite at the company's GLP-certified facilities in Barcelona.
  • Specipig Miniature Pigs for Preclinical Research Proprietary miniature pigs bred and supplied by Specipig for use in preclinical biomedical, pharmaceutical, and medical device research programs. Provided as an integrated animal model supply alongside CRO services.

Quantifiable outcome

  • Over 200 customized projects completed in 14 countries over 12 years

Companies that use Specipig

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Specipig technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Specipig partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • UPyThercoreStrategic or Co-development Partner · 1 January 2023UPyTher selected Versa Biomedical for development of their custom drug delivery solution for treatment of peritoneal diseases including metastasized colorectal and ovarian cancer.
  • Germans Trias i Pujol Institute (IGTP)coreStrategic or Co-development Partner · 1 January 2022Collaborative research partnership where CMN research group researchers developed and established a novel reproducible and minimally invasive ischemic stroke model in swine, leveraging Versa Biomedical's facilities and expertise.
  • Zircon MedicalcoreStrategic or Co-development Partner · 1 January 2022Zircon selected Versa Biomedical for preclinical development of Y-TZP Zirconia implant solution, conducting studies for dental implant applications.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Specipig competitors and assessment

Company assessment

Broad incumbents

  • WuXi AppTec (WuXi Biology / Preclinical): Global preclinical CRO with extensive in vivo and safety assessment services. Specipig and WuXi compete for outsourced preclinical study contracts from international pharma/biotech sponsors, though WuXi operates at much greater scale.
  • Charles River Laboratories: Global preclinical CRO with broad species coverage including swine models for safety assessment and biomedical research. Comparable as a direct competitor in the preclinical CRO category but at vastly larger scale with rodents, NHPs and additional services beyond Specipig's pig-model niche.
  • Labcorp Drug Development (Fortrea): Large CRO offering preclinical services including large-animal and medical device programs. A relevant buyer consideration for any sponsor choosing between full-service incumbents and a specialized mini-pig CRO like Specipig.
  • Inotiv: Preclinical CRO and research models provider offering surgical and toxicology services, including large-animal capabilities. Competitor for preclinical study outsourcing work across pharma and medical device sponsors.
  • SNBL USA: Preclinical CRO with NHP and large-animal experience supporting safety assessment and regulatory toxicology for pharma and device sponsors. Comparable CRO sale motion and regulatory-grade deliverables to Versa Biomedical's offering.
  • Evotec (Crossbow Therapeutics / Preclinical): Drug discovery and preclinical CRO with growing in vivo capabilities. Indirect competitor for outsourced preclinical work and a potential partner or acquirer of niche preclinical capabilities like Specipig's.

Emerging players

  • Marshall BioResources: Provider of research models including minipigs (Göttingen and Sinclair lines) and contract research services. Comparable as a combined model supplier + services organization targeting the same preclinical sponsor base.
  • Crown Bioscience: Preclinical CRO with oncology and translational research expertise, including large-animal and surgical model capability. Comparable preclinical services target customer and CRO sale motion (pharma/biotech sponsorship).

Direct peers

  • Sinclair Research: Preclinical CRO specializing in minipig and other large-animal models for safety, pharmacology and medical device studies. Closest niche competitor given overlapping minipig expertise and sponsor profile (pharma + medtech).
  • Ellegaard Göttingen Minipigs: Leading commercial breeder and supplier of Göttingen minipigs for biomedical research worldwide. Directly comparable to Specipig's animal-model supply side and overlap with the CRO buyer base for porcine preclinical studies.

Market position

Strengths5 records

Weaknesses6 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Specipig social profiles

Digital presence

Specipig compliance and trust

Trust signal

Compliance3 records

Specipig financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Specipig leadership team

Management profile

Number of profiles

Profiles1 record

Specipig funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Specipig M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Specipig

What does Specipig do?

Specipig is a preclinical Contract Research Organization specialized in porcine (pig) models that delivers contract research services to pharmaceutical, biotechnology, and medical device companies. The company combines its own miniature pig breeding program with full-service CRO capabilities (under the Versa Biomedical brand), designing flexible, ad hoc in vivo studies including preclinical trials, pharmacokinetics, toxicokinetics, efficacy and safety studies, and biocompatibility/device testing under GLP, ISO 13485, and ISO 9001 certifications.

Is Specipig a public or private company?

Specipig is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Specipig founded?

Specipig was founded in 2013. It employs 1 to 10 people.

Where is Specipig based?

Specipig is headquartered in Barcelona, Spain, in the Europe region.

How does Specipig make money?

One revenue line is on record: preclinical Contract Research Services.

Who are Specipig's main competitors?

Broad incumbents on record are WuXi AppTec (WuXi Biology / Preclinical), Charles River Laboratories, Labcorp Drug Development (Fortrea), Inotiv, SNBL USA and Evotec (Crossbow Therapeutics / Preclinical). Emerging players are Marshall BioResources and Crown Bioscience. Direct peers are Sinclair Research and Ellegaard Göttingen Minipigs.

Does Specipig have an API?

No public API is recorded for Specipig.

What industry is Specipig in?

Specipig's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK), with a secondary code of HLAGAAAC, Toxicology & Safety Assessment CROs (GLP). Its NAICS code is 112 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales